English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Impact of nrTMS Therapy on the Progress of Neurorehabilitation

Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
StatusRecruiting
Sponsors
Technische Universität München

Keywords

Abstract

Low-frequency navigated repetitive transcranial magnetic stimulation (nrTMS) of the non-damaged hemisphere to increase cortical excitability of the damaged hemisphere and to reduce the increased neuronal inhibition in patients suffering from new surgery-related paresis after brain tumor resection

Description

Postoperative loss of motor function greatly impairs the patients' quality of life and life expectancy of patients with brain tumors is significant limited. Hence the reduction of time spent on neurorehabilitation is very important.

Inclusion of patients that underwent brain tumor resection with a surgery-related paresis of the upper extremity.

Randomized controlled and double blinded trial - 2/3 nrTMS, 1/3 sham. Fifteen minutes low-frequency nrTMS (1 Hz) of the uneffected hemisphere at 7 consecutive days: nrTMS group or sham group. Thirty minutes physical therapy of the upper extremity in both groups.

MRI, nTMS motor mapping, assessments for motor status of upper extremity including Fugl-Meyer-Assessment (FMA), National Institution of Health Stroke Scale (NIHSS), Jebsen Taylor Hand Function Test (JTHFT), Nine Hole Peg Test (NHPT), and Karnofsky Performance Scale (KPS) postoperatively, after the 7th day of intervention and after 3 months.

Dates

Last Verified: 05/31/2019
First Submitted: 05/16/2019
Estimated Enrollment Submitted: 06/09/2019
First Posted: 06/10/2019
Last Update Submitted: 06/09/2019
Last Update Posted: 06/10/2019
Actual Study Start Date: 05/31/2015
Estimated Primary Completion Date: 05/31/2019
Estimated Study Completion Date: 06/30/2019

Condition or disease

Transcranial Magnetic Stimulation, Repetitive

Intervention/treatment

Device: nrTMS group

Procedure: physical therapy

Phase

-

Arm Groups

ArmIntervention/treatment
Active Comparator: nrTMS group
15 minutes low-frequency nrTMS (1 Hz) of the uneffected hemisphere at 7 consecutive days
Device: nrTMS group
Sham Comparator: sham group
15 minutes sham stimulation of the uneffected hemisphere at 7 consecutive days

Eligibility Criteria

Ages Eligible for Study 18 Years To 18 Years
Sexes Eligible for StudyAll
Accepts Healthy VolunteersYes
Criteria

Inclusion Criteria:

- New surgery-related paresis of upper extremity after brain tumor resection

- Written informed consent for participation

Exclusion Criteria:

- Contraindications for MRI

- Contraindications for nrTMS

- Only biopsy instead of tumor resection

- Patients without preserved MEP response as measured by postoperative nTMS motor mapping

Outcome

Primary Outcome Measures

1. Change of Fugl-Meyer Assessment (FMA) [Between first day of intervention and 3-months follow up]

Assessment upper extremity

Secondary Outcome Measures

1. Nine Hole Peg Test (NHPT) [First day of intervention = postoperatively, after the 7th day of intervention and after 3 months]

Fine motor skills upper extremity

2. National Institutes of Health Stroke Scale (NIHSS) [First day of intervention = postoperatively, after the 7th day of intervention and after 3 months]

The scale measures neurological outcome; Total score is reported; Scores on the NIHSS range from 0 to 42, with higher scores indicating more severe disability

3. Jebsen Taylor Hand Function Test (JTHFT) [First day of intervention = postoperatively, after the 7th day of intervention and after 3 months]

Functionality upper extremity

4. Karnofsky Performance Status (KPS) [First day of intervention = postoperatively, after the 7th day of intervention and after 3 months]

The scale measures general oncological outcome; the total score is reported; Scores on the KPS scale range from 0% to 100%, with higher scores indicating less disability and and better quality of life in cancer patients

Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge